Monday, March 15, 2021

FDA Launches New COVID-19 EUA FAERS Public Dashboard - Drug Information Update

If your email program has trouble displaying this email, view it as a web page.

FDA Center for Drug Evaluation and Research Division of Drug Information

FDA launches new COVID-19 EUA FAERS Public Dashboard

Today, the Food and Drug Administration launched an important update to the FDA Adverse Event Reporting System (FAERS) Public DashboardThe FAERS Public Dashboard is a user-friendly search tool that improves access to data on adverse events associated with the use of drug and therapeutic biological products submitted to FAERS. During public health emergencies, the FDA may authorize Emergency Use Authorization (EUA) to facilitate the availability and use of medical countermeasures. To expand access to adverse event safety data during the COVID-19 public health emergency, FDA has launched the COVID-1EUA FAERS Public Dashboard. This dashboard provides weekly updates of adverse event reports submitted to FAERS for drugs and therapeutic biological products used under an EUA during the COVID-19 public health emergency The COVID-19 EUA FAERS Public Dashboard was made available to the public to increase transparency and provide more efficient access to safety information.  

For more information on using the FAERS Public Dashboard and COVID-19 EUA FAERS Public Dashboard and to access, please visit the FAERS Public Dashboard page and the FAERS dashboard FAQ page.  

Access COVID-19 EUA FAERS Dashboard


This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment